Related Experiment Video
Updated: Jul 24, 2026

Measuring Cardiac Autonomic Nervous System (ANS) Activity in Children
Published on: April 29, 2013
Design and implementation of the North American Pediatric Cardiomyopathy Registry
M A Grenier1, S K Osganian, G F Cox
1Children's Hospital at Strong, University of Rochester, NY, USA.
Insights
The Pediatric Cardiomyopathy Registry (PCMR) established a large database for pediatric cardiomyopathy, collecting data on children with the condition. This registry aims to improve understanding of the disease
Area of Science:
- Pediatric Cardiology
- Epidemiology
- Clinical Research
Background:
- Pediatric cardiomyopathy presents significant health challenges in individuals under 18.
- Limited data exists on the epidemiology and clinical course of pediatric cardiomyopathies.
- Developing targeted treatments requires a better understanding of disease etiology and natural history.
Purpose of the Study:
- To establish the Pediatric Cardiomyopathy Registry (PCMR) for children aged 18 years or younger.
- To describe the epidemiologic features and clinical course of pediatric cardiomyopathies.
- To facilitate the development of etiology-specific treatments for pediatric cardiomyopathy.
Main Methods:
- Recruited 61 private and institutional pediatric cardiomyopathy practices in the US and Canada.
- Established a prospective, population-based cohort and a retrospective cohort (diagnosed 1991-1996).
- Collected annual follow-up data on all participating patients.
Main Results:
- As of June 1999, the PCMR included 337 prospectively identified and 990 retrospectively identified patients.
- Demonstrated the feasibility of creating a large sociodemographic and clinical database for pediatric cardiomyopathy.
- The registry successfully aggregated data from multiple clinical sites.
Conclusions:
- The PCMR provides a robust platform for studying pediatric cardiomyopathy.
- The registry will yield precise incidence estimates and enhance understanding of the disease's natural history.
- This cooperative effort is crucial for advancing research and treatment of pediatric cardiomyopathy.
Abstract:
The Pediatric Cardiomyopathy Registry (PCMR) was established to describe the epidemiologic features and clinical course of selected cardiomyopathies in patients aged 18 years or younger and to promote the development of etiology-specific treatments. Sixty-one private and institutional pediatric cardiomyopathy practices in the United States and Canada were recruited to participate in the PCMR. The registry consists of a prospective, population-based cohort of patients in 2 regions (New England and the Central Southwestern United States) and a retrospective cohort of patients diagnosed between 1991 and 1996. Annual follow-up data are collected on all patients. As of June 1999, the PCMR consisted of 337 prospectively identified and 990 retrospectively identified patients. The PCMR has demonstrated the feasibility of establishing a large database of sociodemographic and clinical information on children with pediatric cardiomyopathy. Through this cooperative effort, the PCMR will obtain precise estimates of the incidence of pediatric cardiomyopathy and a better understanding of the natural history of this disease.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management

